Terms of service

MAMSA, INC. Terms of Service
 Last Updated: June 1, 2026

IMPORTANT MEDICAL DISCLAIMER

The Service is for screening and informational purposes only. It does not constitute a medical diagnosis, treatment recommendation, cure, or prevention measure for any disease or condition. Outputs produced by the Service are informational in nature and do not replace professional medical advice. Always consult a qualified healthcare professional for medical decisions. If you are experiencing a medical emergency, contact emergency services immediately and do not rely on this Service.

1. DEFINITIONS

The following terms have the meanings set forth below. Words in the singular include the plural and vice versa.

1.1 "Company," "we," "us," or "our" means Mamsa, Inc., a Delaware corporation, EIN 38-4397456, Delaware File No. 10613776, with its registered address at 131 Continental Dr, Suite 305, Newark, DE 19713, United States.

1.2 "User" or "you" means any natural person who accesses or uses the Service for personal, non-commercial purposes. Persons seeking to use the Service for business purposes must contact the Company separately pursuant to Section 2.3.

1.3 "Service" means all services offered by the Company through its website and platform, including the voice biomarker analysis platform, health screening outputs, and any associated features or functionalities.

1.4 "Software" means the computer system employing artificial intelligence methods to perform voice biomarker analysis tasks, licensed to the Company by the Author under the terms of a separate licensing agreement.

1.6 "License" means the right granted by the Author to the Company to install, use, copy, and otherwise process the Software under the conditions established in the relevant licensing agreement.

1.7 "AI" means artificial intelligence.

1.8 "AI Act" means Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024, laying down harmonized rules on artificial intelligence and amending certain prior EU regulations and directives (the Artificial Intelligence Act).

1.9 "GDPR" means Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation).

1.10 "HIPAA" means the Health Insurance Portability and Accountability Act of 1996, as amended, and all implementing regulations thereunder.

1.11 "ARS" means alternative dispute resolution.

1.12 Any reference to a law or regulation includes all amendments, extensions, re-enactments, and associated implementing regulations. Where applicable, references include equivalent legislation in any jurisdiction where these Terms apply.

2. INTRODUCTION AND ACCEPTANCE

2.1 These Terms of Service ("Terms") govern your access to and use of the Service provided by Mamsa, Inc.

2.2 By accessing or using the Service, you agree to be bound by these Terms in their entirety. If you do not agree to these Terms, you must not use the Service.

2.3 Any person, whether natural or legal, seeking to use the Service for commercial or business purposes is required to contact the Company separately to negotiate bespoke terms. These Terms do not apply to business or commercial use.

2.4 You must be at least 18 years of age to use the Service. By using the Service, you represent and warrant that you meet this eligibility requirement and that you have the legal capacity to enter into a binding agreement.

3. DESCRIPTION OF THE SERVICE

3.1 The Company operates a software platform that analyzes voice biomarkers and makes that analysis available to Users. Users may elect to share their analysis results with third parties, including physicians, to support clinical decision-making with respect to the User's health status.

3.2 The AI technology employed by the Company analyzes voice biomarkers to generate information that may be used for further evaluation by healthcare personnel. The outputs of the Service are informational in character only and do not constitute a diagnosis. They do not represent recommendations or clinical interventions by any third party.

3.3 The Service is not intended to diagnose, treat, cure, or prevent any disease or medical condition, and does not replace professional medical advice or evaluation.

3.4 While the Company's technology achieves high accuracy rates in testing, no screening tool is 100% accurate. Results may include false positives or false negatives. Users acknowledge and accept this inherent limitation.

3.5 The Company strives to maintain continuous service availability but cannot guarantee uninterrupted access. The Service may be subject to maintenance, updates, or technical issues that temporarily affect availability.

4. PERMITTED USE

4.1 You may use the Service only for lawful purposes, in accordance with these Terms, and in compliance with applicable law, including applicable European Union law where relevant.

4.2 You agree not to misuse the Service, interfere with the Software or its source code, or otherwise negatively affect the provision of the Service. Prohibited conduct includes, without limitation:

• Attempting to reverse-engineer, decompile, or disassemble the Software;
• Providing false, misleading, or inaccurate information when using the Service;
• Using the Service in any manner that could damage, disable, overburden, or impair the platform;
• Using the Service for any commercial purpose without a separately negotiated agreement;
• Circumventing or attempting to circumvent any security or access control measures.

4.3 You agree to provide clear, unaltered voice recordings and to use the Service solely for its intended screening purposes.

4.4 The Company reserves the right to suspend or terminate your access to the Service for any violation of these Terms, fraudulent or abusive use, or for any other conduct the Company reasonably determines to be harmful.

5. PRIVACY AND DATA PROTECTION

5.1 The Company's collection, use, and protection of information provided by Users is governed by the Company's Privacy Policy, available on the Company's website. The Privacy Policy is incorporated into these Terms by reference.

5.2 You are responsible for maintaining the confidentiality of your account login credentials and for all activity that occurs under your account.

5.3 You are responsible for ensuring that all data you submit to the Software in connection with the Service complies with applicable privacy law.

5.4 Where the GDPR applies, you qualify as a data subject. Accessing the Service requires you to provide explicit consent to the processing of your sensitive personal data by clicking "I Agree" at the point of uploading your voice sample.

5.5 You have the right to request from the Company the correction or supplementation of your personal data by means of a supplementary statement, which the Company shall make available via its website.

5.6 You may withdraw your consent to the processing of personal data at any time. Upon withdrawal, the Company is obligated to delete the personal data provided, without undue delay.

5.7 During the period in which consent to the processing of personal data remains valid, you have the right to obtain confirmation from the Company as to whether your personal data is being processed.

5.8 You may request restriction of the processing of your personal data where: (i) you have contested the accuracy of the data; (ii) the processing is unlawful; (iii) the Company no longer requires the data but you need it for legal claims; or (iv) you have exercised your right to object under the GDPR.

5.9 You may request that the Company inform you of the recipients to whom your personal data has been disclosed and notify you of any changes affecting such data.

5.10 You have the right to lodge a complaint with the supervisory authority in your jurisdiction if you believe the Company has violated the GDPR or applicable data protection law.

5.11 Without prejudice to any other administrative or extrajudicial remedy, you are entitled to seek redress either as a result of a legally binding decision of a supervisory authority or where you believe that the processing of your personal data infringes the GDPR.

5.12 Where you request confirmation of the processing of your personal data, the Company must also provide you with a copy. Additional copies may be subject to a reasonable fee.

5.13 The Company will delete your personal data without undue delay where: (i) you withdraw consent; (ii) the data was processed unlawfully; (iii) the data is no longer necessary for the purposes for which it was collected; or in any other circumstances set out in Section 7.4 of these Terms.

5.14 The Company is not obligated to delete your personal data if retention is necessary for the exercise or defense of legal claims, to protect freedom of expression and information, or where required in the public interest in the area of public health pursuant to the GDPR.

5.15 Where the Company modifies, deletes, or restricts the processing of your personal data, it shall inform both all third parties to whom the data was previously disclosed and you directly.

5.16 The Company complies with HIPAA and applicable US federal and state privacy laws with respect to protected health information. Enterprise-grade encryption is applied to all data, and regular security audits and compliance reviews are conducted. No data is shared with third parties without your consent, except as required by law.

6. INTELLECTUAL PROPERTY

6.1 The Company is an authorized user of the Software, technology, trademarks, content, and all other components on its website necessary for the provision of the Service. Your use of, and/or payment for, the Service does not confer upon you any rights in or to any components used in the provision of the Service, nor does it grant you any license or sublicense.

6.2 The Service, including all software, algorithms, designs, and content, is protected by applicable intellectual property laws. The Company owns or licenses all rights to the Service, including proprietary AI algorithms and models, trademarks, logos, brand elements, and all user interface designs.

6.3 You are granted a limited, personal, non-transferable, non-sublicensable, revocable license to use the Service for personal health screening purposes in accordance with these Terms. You retain the right to your personal data and analysis results, and the right to request data deletion subject to applicable legal requirements.

7. DATA SECURITY AND AI COMPLIANCE

7.1 The Company maintains the security of its Services and has implemented appropriate administrative, technical, organizational, and physical measures to protect sensitive data obtained from Users, in accordance with recognized security standards including the GDPR and the AI Act. These measures are regularly reviewed and updated in line with changes in applicable law, and appropriate documentation is maintained.

7.2 The Company processes User personal data fairly, transparently, for clearly specified and legitimate purposes, and in compliance with applicable law, the GDPR, and the AI Act.

7.3 The Company stores and protects data in such a manner as to prevent access by any unauthorized third party.

7.4 In the event of a personal data breach, the Company will notify the relevant supervisory authority within 72 hours of becoming aware of the breach. The same obligation applies to any processor that notifies the Company of a breach.

7.5 The Company is not obligated to notify Users of a personal data breach where the circumstances described in Article 34(3) of the GDPR are satisfied.

7.6 The Company has designated a data protection contact person, whose contact details are published on the Company's website and have been provided to the relevant supervisory authority.

7.7 The Company takes all reasonable steps to ensure that personal data is not handled in a manner that could seriously prejudice Users' rights and freedoms, including conducting and consulting its data protection officer on data protection impact assessments (DPIA) pursuant to Article 35 of the GDPR.

7.8 The Company has assessed, pursuant to the AI Act, that the Software and its Services do not constitute an AI system that poses risks of significant harm to Users by reason of their age, disability, or particular social or economic situation.

7.9 The Company has assessed, pursuant to the AI Act, that the Software and its Services are not systems that:

• Categorize Users into groups on the basis of biometric data by reference to race, political opinion, trade union membership, religious or philosophical belief, sexual orientation, or information concerning sexual life;
• Perform real-time remote biometric identification of individuals in publicly accessible spaces;
• The Company uses Users' voice samples solely for the purposes permitted under the GDPR.

7.10 The Company does not use the Software or Service as an AI system to record voice as a biometric identifier enabling identification of a User on the basis of vocal characteristics.

7.11 Voice recognition or voice authentication is permissible only where:

• The User has provided explicit consent, or another lawful basis under the GDPR exists for the processing of special categories of data;
• Such use is strictly necessary and proportionate to the intended and anticipated purpose;
• Appropriate technical and organizational measures for the protection of such data are in place, including encryption and access minimization;
• It does not infringe the prohibitions or restrictions on certain biometric and identification AI applications established by the AI Act.

7.12 The Company ensures that the Software and Services, as AI systems, are deployed only after fulfilling all applicable requirements and conformity assessment procedures under applicable law.

7.13 The Company has adopted the measures required for the use of the Software and Services as a high-risk AI system under the AI Act, including:

• Subjecting the Software and Services to a conformity assessment procedure and preparing the corresponding declaration of conformity;
• Affixing CE marking in an accessible and visible location on its website in relation to the Software and Services;
• Fulfilling all applicable registration and compliance obligations.

7.14 The Company uses the Software and provides the Service in an ethical and responsible manner and adheres to applicable international standards, including ISO 42001 and ISO/IEC 2382-37:2022, for the development and deployment of AI systems. The Company implements measures to reduce bias, ensure transparency, and maintain accountability.

7.15 The Company may develop and test AI features of the Software and/or Service using anonymized data or data provided with User consent. User data will be used for training or improving AI features only where the User has given explicit consent. The Company ensures that Users retain meaningful control over decisions made by or in connection with the AI system.

7.16 The Company continuously monitors the performance of the Software and Services to detect potential risks, including model drift, inaccuracy, or unintended bias.

8. PAYMENT TERMS

8.1 Basic voice analysis features are available free of charge.

8.2 Premium features are available for a one-time payment of USD 49.00. Payment is processed through secure, encrypted channels. Access to premium features is granted immediately upon confirmation of payment.

8.3 Due to the immediate delivery of digital health analysis, refunds are generally not available. The Company will consider refunds on a case-by-case basis in the event of documented technical failures or service non-delivery.

9. LIMITATION OF LIABILITY

9.1 The Company warrants that the Services possess the functional characteristics and qualities described on its website. The Company does not warrant that the Services will meet all of your requirements or that they will operate without interruption or error.

9.2 The Company warrants that it will provide the Services in compliance with applicable law so as not to jeopardize the legal protection of the Service, and that it will refrain from any conduct that could, by its nature, cause harm or damage to Users.

9.3 To the maximum extent permitted by applicable law, the Company shall not be liable for any indirect, incidental, special, consequential, or punitive damages arising out of or in connection with your use of or inability to use the Service, including but not limited to loss of data, loss of profits, or harm resulting from reliance on the Service's outputs for medical decisions.

10. TERMINATION

10.1 Either party may terminate this agreement at any time. The Company reserves the right to suspend or terminate your access to the Service for any violation of these Terms, fraudulent or abusive use, provision of false or misleading information, or attempted circumvention of the Software.

10.2 Upon termination, your access to the Service will cease. Your data will be retained and handled in accordance with the Privacy Policy and applicable legal requirements.

11. AMENDMENTS

11.1 The Company may amend these Terms at any time. Updated Terms will be published on the Company's website with the effective date of the amendment.

11.2 Continued use of the Service following publication of amended Terms constitutes acceptance of the updated Terms. If you do not agree to the amended Terms, you must discontinue use of the Service.

12. GOVERNING LAW AND DISPUTE RESOLUTION

12.1 These Terms are governed by and construed in accordance with the laws of the State of Delaware, United States, without regard to conflict of law principles, and, where applicable, the law of the European Union and relevant Member State law.

12.2 In the event of a dispute, you are entitled to seek protection of your rights and legally protected interests through the following mechanisms:

• Informal resolution directly with the Company;
• Alternative dispute resolution proceedings by submitting a complaint to an ARS body, the list of which for each EU Member State is published by the European Commission; or
• Formal legal proceedings through the European Small Claims Procedure or before the court of competent jurisdiction.

12.3 For disputes not subject to EU consumer protection or ARS mechanisms, the courts of the State of Delaware, United States, shall have exclusive jurisdiction.

12.4 Nothing in this Section limits any mandatory consumer rights you may hold under the law of your country of residence.

13. CONTACT

Mamsa, Inc. 131 Continental Dr, Suite 305 Newark, DE 19713 United States EIN: 38-4397456 Delaware File No.: 10613776

For questions, requests, or notices regarding these Terms, privacy matters, or data protection, please contact us at:

Email: legal@mamsacare.com Website: www.mamsacare.com